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Genome-wide profiling and next-generation based sequencing studies have dramatically improved our 
understanding of embryonal brain tumor (EBT) biology in the recent years. However, the vast majority of these 
studies are based on the assumption that single biopsies are representative for the entire primary tumor. Intratumor 
heterogeneity constitutes a common phenomenon previously described in renal cell carcinoma (RCC) and 
high-grade glioma (HGG). Highly disparate molecular profiles of spatially separated tumor areas within the same 
tumor may preclude development of molecularly targeted therapies based on single tumor biopsies. 
Material and methods 
To address this issue, we conducted multiregion whole exome sequencing, high-resolution DNA copy number 
analysis (Cytoscan HD), and transcriptional profiling on 39 distinct pediatric and adult tumors with a median of six 
spatially distant biopsies per tumor (range 4-11). Histological entities included AT/RT (n = 2), HGG (n = 17), 
medulloblastoma (n = 9), medulloepithelioma (n = 1), and RCC (n = 10). We assessed the degree of intratumor 
heterogeneity and subgroup affiliation using integrated genomics approaches. 
Results 
Embryonal brain tumors demonstrated highly spatially homogenous transcriptomes. In contrast to adult 
glioblastoma, we showed that subgroup affiliation was stable in multiregion biopsies from the same 
medulloblastoma patient. Furthermore, EBT displayed highly similar focal and broad DNA copy number 
alterations compared to HGG and RCC. Multiregion sequencing further reinforced the relatively higher degree of 
intratumor homogeneity in EBT. Compared to HGG or RCC, somatic mutations in EBT were much more likely to 
be ubiquitous throughout the tumor. 
Conclusions 
The relative spatial homogeneity of EBT suggests that limited biopsies are representative of the tumor genomics 
landscape, which has important implications for biological classification and development of targeted therapies for 
these tumors. 
